Showing results (871-880 of 933) with videos related to
Sort By:
Pageof 94
Investigative Ophthalmology & Visual Science|August 18, 2012
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.Cells|June 25, 2025
Wnt/PKC Signaling Inhibits Sensory Hair Cell Formation in the Developing Mammalian CochleaJoanna F Mulvaney, Erynn M Layman, Farhana Feroze-Merzoug, et al.Cancer Biology & Therapy|January 30, 2013
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trialJeffrey R Infante, Hendrik-Tobias Arkenau, Johanna C Bendell, et al.Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)David R Spigel, Mark S Rubin, Victor G Gian, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1992
Human prostate cancer model: roles of growth factors and extracellular matricesL W Chung, W Li, M E Gleave, et al.The Science of the Total Environment|December 5, 2002
Antimicrobial residues in animal waste and water resources proximal to large-scale swine and poultry feeding operationsEnzo R Campagnolo, Kammy R Johnson, Adam Karpati, et al.Journal of Crohn'S & Colitis|December 26, 2022
Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBDLawrence Bai, Denis Dermadi, Laurynas Kalesinskas, et al.Archives of Environmental Health|September 17, 2004
Use of isotope ratios to identify sources contributing to pediatric lead poisoning in PeruLuke P Naeher, Carol S Rubin, Mauricio Hernandez-Avila, et al.JIMD Reports|February 23, 2013
Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by dietS Rubin, A L Le Piffer, M B Rougier, et al.Cancer|June 22, 2010
Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research ConsortiumJohn D Hainsworth, Jeffrey R Infante, David R Spigel, et al.Pageof 94